Politics
A new survey by the Independent Community Bankers of America (ICBA) reveals that a significant majority of Americans view the Secure and Fair Enforcement Regulation (SAFER) Banking Act as a…
House Minority Leader Hakeem Jeffries (D-NY) voices support for the Biden administration’s move to reschedule marijuana. Calls for Legislative Follow-Up Jeffries advocates for congressional action, urging passage of the Senate…
A day after the DEA’s announcement regarding marijuana rescheduling, Smart Approaches to Marijuana (SAM) is gearing up for a legal battle against the reform. Rescheduling Legal Defense Fund SAM reaches…
Senate Democrats propose significant changes to federal hemp laws in their version of the 2024 Farm Bill. Regulatory Barriers for Hemp Farmers The bill aims to reduce regulatory barriers for…
In a recent ruling, a New Jersey appellate court upheld the state’s recreational cannabis law, declaring its ability to “coexist” with federal marijuana enforcement laws. The decision came in response…
Federal Guidance Expansion Expected As the U.S. Drug Enforcement Administration (DEA) moves toward rescheduling marijuana, anticipation grows regarding potential updates to federal guidance on enforcement priorities. The former U.S. deputy…
The Biden administration has recently reiterated its commitment to cannabis rescheduling, emphasizing a pledge made by President Biden during his 2020 election campaign. The White House has underscored its dedication…
A congressional committee has approved a GOP-led psychedelics bill focused on military veterans’ access. The proposal, advanced by Rep. Derrick Van Orden (R-WI), aims to address the potential therapeutic benefits…
Committee Testimony on Medical Marijuana Bill Lawmakers in South Carolina’s House committee hear testimony on Tuesday regarding a Senate-passed bill to legalize medical marijuana. Unlikelihood of a House Vote Despite…
The Drug Enforcement Administration’s (DEA) recent decision to reschedule cannabis from Schedule I to Schedule III marks a significant turning point in U.S. drug policy. This move holds immense implications…
